Correlation Between Quantitative PSMA PET Parameters and Clinical Risk Factors in Non-Metastatic Primary Prostate Cancer Patients

BACKGROUND: PSMA PET is frequently used for staging of prostate cancer patients. Furthermore, there is increasing interest to use PET information for personalized local treatment approaches in surgery and radiotherapy, especially for focal treatment strategies. However, it is not well established wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Zschaeck, Sebastian, Andela, Stephanie Bela, Amthauer, Holger, Furth, Christian, Rogasch, Julian M., Beck, Marcus, Hofheinz, Frank, Huang, Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074726/
https://www.ncbi.nlm.nih.gov/pubmed/35530334
http://dx.doi.org/10.3389/fonc.2022.879089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074726/
https://www.ncbi.nlm.nih.gov/pubmed/35530334
http://dx.doi.org/10.3389/fonc.2022.879089

Ejemplares similares